Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.25
Bid: 9.00
Ask: 9.50
Change: 0.00 (0.00%)
Spread: 0.50 (5.556%)
Open: 9.25
High: 9.25
Low: 9.25
Prev. Close: 9.25
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

6 Dec 2021 14:05

RNS Number : 7152U
SkinBioTherapeutics PLC
06 December 2021
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGZMGZDVKGMZM

Date   Source Headline
4th Dec 20207:00 amRNSFinal Results
2nd Dec 202011:16 amRNSNotice of Results
2nd Nov 20204:15 pmRNSHolding(s) in Company
2nd Nov 20203:49 pmRNSHolding(s) in Company
30th Oct 202012:23 pmRNSResult of General Meeting and Open Offer
14th Oct 20207:00 amRNSPlacing and Open Offer
18th Sep 20204:48 pmRNSGrant of Options
8th Sep 20207:19 amRNSAppointment of Senior Medical Advisor
31st Jul 20207:00 amRNSProduct Development Progress
7th Jul 20207:00 amRNSBusiness Update
26th Jun 20207:00 amRNSChange of Adviser
23rd Jun 20204:29 pmRNSHolding(s) in Company
1st Jun 20203:45 pmRNSHolding(s) in Company
17th Apr 20204:24 pmRNSHolding(s) in Company
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSHalf Year Results
19th Feb 20207:00 amRNSAgreement signed with Winclove Probiotics B.V.
19th Dec 201911:47 amRNSResult of AGM
26th Nov 20198:50 amRNSNotice of AGM
26th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSCommercial Agreement
6th Nov 201910:38 amRNSHolding(s) in Company
28th Aug 20192:05 pmRNSSecond Price Monitoring Extn
28th Aug 20192:00 pmRNSPrice Monitoring Extension
28th Aug 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSBusiness Update and Board Changes
18th Apr 20197:00 amRNSDirector Appointment
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSSkinBiotix shows efficacy in first human study
29th Mar 20197:00 amRNSCEO Designate Appointment
18th Feb 20197:00 amRNSIssue of Equity
14th Feb 20197:00 amRNSHalf year results
1st Feb 20193:30 pmRNSAppointment of Joint Broker
31st Jan 20198:35 amRNSUpdate on human study and IP portfolio extension
31st Jan 20197:00 amRNSUpdate on human studies & IP portfolio extension
20th Nov 20187:00 amRNSCommencement of final phase of human studies
19th Nov 201812:30 pmRNSResult of AGM
7th Nov 20187:00 amRNSSkinBiotix® generates positive data in human study
25th Oct 20187:00 amRNSFull year results
19th Sep 20187:00 amRNSHuman study commenced
18th Sep 20182:05 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
3rd Sep 20187:00 amRNSSkinBiotix technology successful in stability test
16th Aug 201811:05 amRNSSecond Price Monitoring Extn
16th Aug 201811:00 amRNSPrice Monitoring Extension
16th Aug 20187:00 amRNSBusiness Update
3rd Aug 20188:57 amRNSHolding(s) in Company
23rd Jul 20181:13 pmRNSHolding(s) in Company
18th Jul 20187:00 amRNSProvisional ethics approval for human study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.